Biocon Ltd.

Healthcare

24 September, 2019

Biocon buys Pfizer's R&D facility to boost biosimilars development

Indian biotechnology firm Biocon Ltd on Tuesday said it has acquired a Chennai-based research and development (R&D) facility from Pfizer ......

General

21 August, 2019

Grapevine: Temasek, TrueNorth, CPPIB eye Biocon unit stake; PayU may buy PaySense

Singapore state investor Temasek, private equity firm TrueNorth, and Canadian Pension Plan Investment Board (CPPIB) are in separate discussions with ......

Premium

Healthcare

18 May, 2017

True North makes partial exit from drug research firm with strong gains

Private equity firm True North has sold a bulk of its stake in a drug research company, harvesting handsome gains ......

General

22 February, 2016

Budget needs to give a push to healthcare agenda

A healthy workforce is critical for Prime Minister Narendra Modi’s ‘Make in India’ mantra to rev up India’s economic growth. ......

Healthcare

11 August, 2015

IVFA-backed Syngene makes strong market debut, ends day 1 with 24% gain

Syngene International Ltd, the research and development subsidiary of Indian biopharmaceutical major Biocon Ltd, made a strong debut on the ......

Healthcare

17 July, 2015

Biocon to open IPO of R&D arm Syngene end of this month, fixes price band

Biopharmaceutical major Biocon Ltd has fixed the price band for the initial public offering (IPO) of its research and development ......

Healthcare

23 April, 2015

Biocon to sell 10% stake in IVFA-backed R&D arm Syngene through offer-for-sale

Biopharmaceutical major Biocon Ltd's research and development arm Syngene International Ltd has filed draft red herring prospectus (DRHP) with securities ......

Healthcare

23 January, 2015

Biocon plans IPO for IVFA-backed drug discovery services arm Syngene

Biocon Ltd is looking to offload up to 15 per cent in its research arm Syngene International, a firm in ......

Healthcare

03 June, 2014

Biocon extends pact between Syngene and Bristol-Myer for five more years

Bangalore-based Biocon Ltd, India’s largest biotechnology company founded by Kiran Mazumdar-Shaw in 1978, has announced a five-year extension of its ......

Premium

Pharmaceuticals

07 May, 2014

Licensing income can bring upsides to our target of $1B revenue by 2018: Kiran Mazumdar-Shaw of Biocon

Biocon Ltd is India’s largest biotechnology company founded by Kiran Mazumdar-Shaw in 1978. The company, which started with an initial ......